<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release

Our History, Values, People, Planet

Learn more about us

Our Mission:
To work side-by-side with our customers in order to improve patients’ lives by bringing new biopharmaceuticals to market.

AGC Biologics is a global CDMO based in Seattle, Washington, USA. The company provides pharmaceutical development and manufacturing services for protein-based biologics and cell and gene therapies. With seven facilities and teams of scientists across three continents, we have the resources and the available capacity you need to accelerate your race to GMP. From development to clinical trials, to full-scale commercialization, we can help you reach your goals at any stage in the drug development and manufacturing process.

We specialize in the following modalities and substances, mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our services range from process development, analytical development, cGMP manufacturing, quality control and quality assurance, and process validation. 

We forge exceptionally strong partnerships with our customers, and we never lose sight of our commitment to delivering reliable and compliant drug substances.


Years of Experience




Customers Served



AGC Biologics is part of AGC Inc.

The AGC Group is a global business conglomerate with over 206 companies and net sales of $14.1 billion during FY2022.

Benefits for AGC Biologics Customers:

  • Financial stability and backing of a global organization
  • Long-term vision and strategic plan for AGC Biologics
  • Access to capital to expand global capabilities and capacity

Our History

In December 2016, CMC Biologics announced that all of its shares were being acquired by AGC Asahi Glass (AGC), a Japanese-based manufacturer of glass, chemicals, and high-tech materials.

AGC Biologics was founded in January 2018 in Bothell, Washington, U.S.A., as a convergence of Asahi Glass Company (AGC) Bioscience, Biomeva GmbH (Heidelberg, Germany), and CMC Biologics to form a global CDMO focused on offering microbial and mammalian capabilities, supporting early-phase, late-phase, and commercial production needs, at small and large scales.

We have since acquired additional facilities and companies around the world, expanding our offerings and creating a strong global network of manufacturing sites stretching across three continents.

Today, AGC Biologics provides world-class development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells.

Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Bothell, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan.


Our Core Values

  • Knowledge
  • Trust
  • Quality
  • Ingenuity
  • Accountability
  • Teamwork

Our People

Our team is committed to a high standard of quality and execution because each and every employee recognizes that meeting the needs of our customers contributes to meeting the needs of providers and patients.

Join our Global Team

Our commitment to our employees, as we build successful teams, helps us achieve the ultimate goal — helping to save patients' lives.

Our employees are recognized as experts in what they do, and we are incredibly proud of the collaboration and ingenuity they use each day to solve complex problems. 

If you value excellence, recognize the importance of collaboration, and strive to lead by example, there is a place for you here at AGC Biologics!

Learn how to join our team

Health & Safety

Responsible stewards of Our Planet

We are committed to meeting the needs of the environment by operating ethically and responsibly. 

Review our Global EHS Policies